The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein

Journal of General Virology

Volumn 88, Issue 9, 2007, Pages 2417-2425

  Onion, David ^a   Crompton, Laura J ^a   Milligan, Donald W ^b   Moss, Paul A H ^a   Lee, Steven P ^a   Mautner, Vivien ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEXON PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL LYSATE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TARGETING; SEROTYPE; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS STRAIN;

CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CONSERVED SEQUENCE; HLA ANTIGENS; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES;

ADENOVIRIDAE;

EID: 34548213295     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82867-0     Document Type: Article

References (62)

1. Adhikary, D., Behrends, U., Moosmann, A., Witter, K., Bornkamm, G. W. & Mautner, J. (2006). Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J Exp Med 203, 995-1006.
2. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. & Heath, W. R. (1998). Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480.
3. Bollard, C. M., Kuehnie, I., Leen, A., Rooney, C. M. & Heslop, H. E. (2004). Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant 10, 143-155.
4. Bordigoni, P., Carret, A. S., Venard, V., Witz, F. & Le Faou, A. (2001). Treatment of adenovirus infections in patients undergoing allogeneic hernatopoietic stem cell transplantation. Clin Infect Dis 32, 1290-1297.
5. Brown, D. M., Roman, E. & Swain, S. L. (2004). CD4 T cell responses to influenza infection. Semin Immunol 16, 171-177.
6. Burns, D. M. & Crawford, D. H. (2004). Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease. Blood Rev 18, 193-209.
7. Chakrabarti, S., Mautner, V., Osman, H., Collingham, K. E., Fagan, C. D., Klepper, P. E., Moss, P. A. & Milligan, D. W. (2002). Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100, 1619-1627.
8. Ebner, K., Pinsker, W. & Lion, T. (2005). Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol 79, 12635-12642.
9. Einsele, H. & Hebart, H. (2004). CMV-specific immunotherapy. Hum Immunol 65, 558-564.
10. Engler, J. A., Mulach, B. & Hong, J. S. (1999). Characterization of the adenovirus fiber protein. In Adenovirus Methods and Protocols, pp. 241-259. Edited by W. S. M. Wold. Totowa, NJ: Humana Press.
11. Feuchtinger, T., Richard, C., Pfeiffer, M., Neuhauser, F., Lucke, J., Handgretinger, R., Grail, J., Bader, P., Klingebiel, T. & other authors (2005). Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 217, 339-344.
12. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F. R. & other authors (2006). Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 134, 64-76.
13. Flomenberg, P., Babbitt, J., Drobyski, W. R., Ash, R. C., Carrigan, D. R., Sedmak, G. V., McAuliffe, T., Camitta, B., Horowitz, M. M. & other authors (1994). Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169, 775-781.
14. + T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol 70, 6314-6322.
15. Fox, J. P., Brandt, C. D., Wassermann, F. E., Hall, C. E., Spigland, I., Kogon, A. & Elveback, L. R. (1969). The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol 89, 25-50.
16. Fox, J. P., Hall, C. E. & Cooney, M. K. (1977). The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 105, 362-386.
17. + T cells in protection against CMV disease. Blood 101, 2686-2692.
18. Garnett, C. T., Erdman, D., Xu, W. & Gooding, L. R. (2002). Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76, 10608-10616.
19. Haase, A. T., Mautner, V. & Pereira, H. G. (1972). The immunogenicity of adenovirus type 5 structural proteins. J Immunol 108, 483-485.
20. Hale, G. A., Heslop, H. E., Krance, R. A., Brenner, M. A., Jayawardene, D., Srivastava, D. K. & Patrick, C. C. (1999). Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23, 277-282.
21. Haveman, L. M., Blerings, M., Legger, E., Klein, M. R., de Jager, W., Otten, H. G., Albani, S., Kuls, W., Sette, A. & Prakken, B. J. (2006). Novel pan-DR-binding T cell epitopes of adenovirus induce proinflammatory cytokines and chemokines in healthy donors. Int Immunol 18, 1521-1529.
22. + adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol 77, 6562-6566.
23. + T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J Immunol 177, 8851-8859.
24. + T-cell memory. Nat Med 7, 913-919.
25. Horwitz, M. S. (2001). Adenoviruses. In Fields Virology, pp. 2301-2326. Edited by B. N. Fields & D. M. Knipe. Philadelphia: Lippincott Williams & Wilkins.
26. Hromas, R., Cornetta, K., Srour, E., Blanke, C. & Broun, E. R. (1994). Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84, 1689-1690.
27. + T lymphocytes. Nature 421, 852-856.
28. Kahn, P. (2003). Update on Merck's AIDS Vaccine Program. IAVI Rep 7.
29. Khanna, R., Burrows, S. R., Steigerwald-Mullen, P. M., Thomson, S. A., Kurilla, M. G. & Moss, D. J. (1995). Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Virology 214, 633-637.
30. Klenerman, P. & Hill, A. (2005). T cells and viral persistence: lessons from diverse infections. Nat Immunol 6, 873-879.
31. Kojaoghlanian, T., Flomenberg, P. & Horwitz, M. S. (2003). The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13, 155-171.
32. Leen, A. M. & Rooney, C. M. (2005). Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol 128, 135-144.
33. + T-helper 1 responses. J Virol 75, 8649-8659.
34. + T cells. Blood 104, 2432-2440.
35. Leen, A. M., Myers, G. D., Sili, U., Huls, M. H., Weiss, H., Leung, K. S., Carrum, G., Krance, R. A., Chang, C. C. & other authors (2006). Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 12, 1160-1166.
36. Lion, T., Baumgartinger, R., Watzinger, F., Matthes-Martin, S., Suda, M., Preuner, S., Futterknecht, B., Lawitschka, A., Peters, C. & other authors (2003). Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102, 1114-1120.
37. + T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J Virol 79, 4896-4907.
38. Lucas, M., Day, C. L., Wyer, J. R., Cunliffe, S. L., Loughry, A., McMichael, A. J. & Klenerman, P. (2004). Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol 78, 7284-7287.
39. Miller, G. & Lipman, M. (1973). Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70, 190-194.
40. Miyamoto, T., Gondo, H., Miyoshi, Y., Shigematsu, H., Minematsu, T., Takenaka, K., Tanimoto, K, Horiuchi, T., Asano, Y. & other authors (1998). Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 100, 348-350.
41. Mullbacher, A., Bellett, A. J. & Hia, R. T. (1989). The murine cellular immune response to adenovirus type 5. Immunol Cell Biol 67, 31-39.
42. Murakami, P. & McCaman, M. T. (1999). Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent dye. Anal Biochem 274, 283-288.
43. Neumann, R., Genersch, E. & Eggers, H. J. (1987). Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 7, 93-97.
44. + T-cell responses from healthy adults. Viral Immunol 14, 403-413.
45. + T-cell epitope. Hum Gene Ther 13, 1167-1178.
46. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. & Stevanovic, S. (1999). SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219.
47. Rawle, F. C., Knowles, B. B., Ricciardi, R. P., Brahmacheri, V., Duerksen-Hughes, P., Wold, W. S. & Gooding, L. R. (1991). Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice. J Immunol 146, 3977-3984.
48. + T-helper and a T-killer cell. Nature 393, 474-478.
49. Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H. & Ward, T. G. (1953). Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84, 570-573.
50. Rux, J. J., Kuser, P. R. & Burnett, R. M. (2003). Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 77, 9553-9566.
51. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. & Melief, C. J. (1998). T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
52. + T cells with optimized HLA class II tetramer staining. J Immunol 175, 6334-6343.
53. Sester, M., Sester, U., Alarcon, S. S., Heine, G., Lipfert S., Girndt, M., Gartner, B. & Kohler, H. (2002). Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 185, 1379-1387.
54. Smith, C. A., Woodruff, L. S., Kitchingman, G. R. & Rooney, C. M. (1996). Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol 70, 6733-6740.
55. Stone, D., Ni, S., Li, Z. Y., Gagger, A., DiPaolo, N., Fang, O., Sandig, V. & Lieber, A. (2005). Development and assessment of human adenovirus type 11 as a gene transfer vector. J Virol 79, 5090-5104.
56. + cytotoxic T cell responses to adenovirus capsid proteins. Virology 350, 312-322.
57. Thirion, C., Lochmuller, H., Ruzsics, Z., Boelhauve, M., Konig, C., Thedieck C., Kutik, S., Geiger, C., Kochanek, S. & other authors (2006). Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther 17, 193-205.
58. Vanniasinkam, T. & Ertl, H. C. (2005). Adenoviral gene delivery for HIV-1 vaccination. Curr Gene Ther 5, 203-212.
59. + T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur J Immunol 36, 2410-2423.
60. Vogels, R., Zuijdgeest,D., van Rijnsoever, R., Hartkoom, E., Damen, I., de Bethune, M. P., Kostense, S., Panders, G., Helmus, N. & other authors (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 77, 8263-8271.
61. Xing, Z., Santosuosso, M., McCormick S., Yang, T. C., Millar, J., Hitt, M., Wan, Y., Bramson, J. & Vordermeier, H. M. (2005). Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr Gene Ther 5, 485-492.
62. Young, L. S., Searle, P. F., Onion, D. & Mautner, V. (2006). Viral gene therapy strategies: from basic science to clinical application. J Pathol 208, 299-318.